Elucidata, a biomedical molecular data company, on Tuesday announced that it has raised $16 million in its Series A funding round led by global investment firm Eight Roads Ventures, with participation from F-Prime Capital, IvyCap Ventures and Hyperplane Venture Capital.
Continue reading with Data Vantage
Venture-backed company data in SE Asia, India, Pakistan, Bangladesh.
Instant investment updates and valuations.
Tailored search, 3 monthly reports.
Industry-trusted platform.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
